Derm Next Door
Derm Next Door
Podcast Description
Derm Next Door is your go-to skin fix from the girlies who get it. Hosted by board-certified dermatologists Dr. Ali Dempsey and Dr. Reem Nabti in the heart of New York City, we’re breaking down skin science, busting beauty myths, and talking all things lifestyle—like your downtown derm besties. Whether it's acne, SPF debates, or skincare trends we love (or don’t), we’re here to keep it real, smart, and always skin-deep.Tune in for honest conversations, expert takes, and a little NYC chaos on the side.
Podcast Insights
Content Themes
The podcast covers a variety of topics related to dermatology and skincare, featuring episodes that discuss acne management, sun protection factor debates, and the latest skincare trends. For example, episodes tackle subjects like debunking popular beauty myths and providing in-depth advice on maintaining healthy skin.

Derm Next Door is your go-to skin fix from the girlies who get it. Hosted by board-certified dermatologists Dr. Ali Dempsey and Dr. Reem Nabti in the heart of New York City, we’re breaking down skin science, busting beauty myths, and talking all things lifestyle—like your downtown derm besties. Whether it’s acne, SPF debates, or skincare trends we love (or don’t), we’re here to keep it real, smart, and always skin-deep.
Tune in for honest conversations, expert takes, and a little NYC chaos on the side.
What happens to your face when you lose weight on a GLP-1, and why is filler making a comeback?
We’re back from the 2026 ASDS Annual Meeting in San Diego. This week, we’re sharing what surprised us, what we’re excited to bring back to clinic, and what we’re still side-eyeing.
- How GLP-1–associated weight loss can change facial volume, and why treatment timing matters
- The return of subtle filler, new wrinkle relaxers, and why menopausal skin is getting more attention
- Early research on topical exosomes and investigational growth factor injections for under-eye hollows
- Derm in the Wild, with celebrity beauty routines and a closer look at XERF and Sofwave
- Skincare industry news and the products that caught our eye at ASDS
A few corrections and clarifications from the episode
- Botox Cosmetic and Boey. Botox Cosmetic is botulinum toxin type A. Boey is a separate type E product authorized in Canada and the EU. FDA label · Health Canada · European Medicines Agency
- Filler migration. Movement of filler away from the injection site is a recognized risk. FDA guidance
- XERF. Human evidence is still limited. Two published studies included 16 and 39 participants. 16-person study · 39-person study
- Journavx. Journavx (suzetrigine) is a prescription non-opioid approved for moderate to severe acute pain in adults. Follow your care team’s instructions about when it’s safe to drive after a procedure. FDA prescribing information
- ZO Skin Health. Galderma announced on October 14 that it had signed an agreement to acquire ZO Skin Health. Galderma announcement
Have a skin question you want us to cover? DM us on Instagram @DermNextDoorNYC.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.